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Abstract: Maternal antibodies play a major role in the development of the immune system of a young animal. Ideally, the transmission of
maternal immunity to the foetus occurs in the uterus. However, in ruminants, as there is no maternal antibody transfer from the mother
to her young by way of the uterus, the antibodies present in the colostrum are a vital necessity for newborn ruminants. After birth, an
unhealthy neonatal period for the young animal and an unhealthy puerperal period for the mother can cause significant financial losses.
In animal husbandry, due to the budget allocated for the treatment of diseases and the economic damage of breeding that can be caused
by lasting problems created by disease, the importance given to preventive medicine has increased further. Therefore, in breeding,
increasing the resistance against the disease agent is preferred instead of treating disease. This situation has resulted in more studies to
improve the level of maternal and colostral antibodies as well as the widespread use of specific and nonspecific immunostimulants in
veterinary medicine. In this review, the factors affecting the quality of ewe colostrum are discussed and the importance of colostrum
quality for a newborn lamb is described. In addition, the methods used today to increase the quality of colostrum are presented.
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1. Introduction
After birth the first secretion from the mammary glands
is called colostrum (1). Colostrum is varied in terms of
colour and the composition varies from that of normal
milk. Between the second and eighth milkings, the
structure of the milk gradually turns normal, and the
secretion between these periods is called transit milk. In
approximately 72 h colostrum turns into normal milk (2).
Colostrum plays a vital role in providing passive
immunisation, thereby contributing to the development
of the gastrointestinal tract, affecting the endocrine and
metabolic systems and providing a source of energy
for young animals to obtain heat generation to protect
themselves from hypothermia (3). In addition, it has a
laxative effect, which helps with the removal of meconium
from the intestine (1).
While the normal milk of ruminants and ewes
contains 12% solids, the same rate for colostrum is
22%. This difference is related to the density of multiimmunoglobulin. In addition, the solid material is richer
in terms of casein, fat, protein, and vitamins A, B12, D,
and E, although it is poorer in terms of lactose. It helps
to prevent the digestion of the immunoglobulins in
the intestine with trypsin inhibitors (4,5). Transferrin
and lactoferrin in colostrum play a role in controlling
diarrhoea by binding iron and limiting the growth of
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some bacteria (4). Colostrum fulfils these responsibilities
through the cellular (polymorph nuclear leukocytes,
macrophages, lymphocytes, and natural killer cells) and
humoral (lactoferrin, the lactoperoxidase–thiocyanate–
hydrogen peroxide system, lysozymes, complements, and
immunoglobulins) factors that it contains (6). In addition,
the colostrum of ruminants and ewes contains insulin-like
growth factor I (IGF-1), insulin (INS), growth hormone
(GH), thyroxine (T4), triiodothyronine (T3), and prolactin
(PRL) (2).
In the last 5 weeks of pregnancy, IgA, IgG, and IgMs
are synthesised by plasma cells in the submucosa of the
mammary gland epithelium, and at the same time IgGs
taken from blood by transudation begin to concentrate
in the secretions of the mammary gland by entering the
gland tissue by way of pinocytosis (4,6). This condition is
associated with an increase in the amount of oestrogen in
the mother. The specific receptors in the mammary gland
epithelium bind IgG1 selectively and take it into the cell by
transcapillary change. IgG1 is moved through the lumen of
the gland and gradually passed into the colostrum. After a
while, the concentration of colostral IgG1 reaches the level
of 3–12 times serum levels and the concentration of serum
IgG1 reduces by approximately 50%. Some of the colostral
IgG1 is absorbed by the intestine, while some of it remains
in the intestine and neutralises pathogenic bacteria (6).
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At the end of a short absorption period in ruminants,
in order to obtain adequate levels of passive immunity,
the colostrum should be of good quality. This quality is
evaluated by the concentration of immunoglobulins in the
colostrum (7).
2. Development of the neonatal immune system
Ruminants’ epitheliochorial placenta is impermeable for
antibodies and this situation causes newborns to be devoid
of immunoglobulins namely, agammaglobulinaemia, or
with a very small amount of immunoglobulin, namely
hypogammaglobulinaemia (8–12). Therefore, newborn
ruminants are in need of the immunoglobulins that they
would absorb from colostrum for passive immunity until
their immune systems develop. However, the transition
of immunoglobulins obtained from colostrum takes
place within a limited period of time. The small intestine
of lambs begins to lose the ability to absorb maternal
antibodies within 24–48 h after birth (8,9,11,13,14). The
end of the intestinal wall permeability to macromolecules
in newborn animals is called “intestinal closure” (4,15).
3. Absorption of colostrum mechanism
Colostral absorption is defined as the passage of substances
in colostrum into blood from the intestinal lumen.
Newborns transfer colostrum to the intestinal canal by
absorbing it. Lambs are able to absorb antitoxins of different
species, polyvinylpyrrolidone (PVP), ruminant colostral
proteins, and substances such as egg proteins within 48 h
after birth (15). Proteins enter the intestinal epithelium of
neonates through the agency of the tubulovesicular system
located at the edge of epithelial cells. From here, they
pass into the intestinal lymphatics and capillary vessels.
Thus, these absorbed immunoglobulins, which are the
structure of protein, pass into circulation and the newborn
completes the transfusion of maternal immunoglobulins.
However, this situation changes for each domestic animal
according to selectivity and intestinal permeability. The
intestine of ruminants has nonselective permeability and
therefore may absorb all immunoglobulin isotypes (8,11).
4. Factors affecting intestinal closure
Immunoglobulins are highly resistant to digestion by
intestinal enzymes. The trypsin inhibitor in colostrum
also plays a role in the formation of this resistance (4). The
average time of intestinal closure has been determined
for IgG as 26.4 h, for IgM as 25 h, and for IgA as 26 h.
However, it has been detected that intestinal closure may
be affected by the initial time that the colostrum was taken
by the newborn. It has been reported that the amount of
colostrum received has no effect on intestinal closure (14).
5. Factors affecting the quality of colostrum
The quality of colostrum correlates directly with the
amount of IgG it contains. This quality decreases as time

goes by after birth (7). It has been reported that dairy
breeds produce more colostrum than beef breeds and
this colostrum is richer in terms of immunoglobulin
(4,16). Likewise, in adult ewes and cows, higher levels
of colostrum and colostral immunoglobulins have been
detected than in youngsters (4,17,18).
Milking before birth, colostrum leaking from the
mother’s udder (19,20), inadequate nutrition of the
mother in terms of energy during pregnancy, long-acting
corticosteroid applications, and lambs not being taken care
by mothers all have a negative effect on the level of colostral
IgG (20). Shubber and Doxey (21) reported that there is no
significant difference in terms of immunoglobulin levels
in colostrum samples taken from the left and right udder
lobes. Another factor affecting the quality of colostrum is
the health condition of the udder. Colostrum milk from
an udder with mastitis should never be given to a young
animal (22).
Al-Sabbagh (22) and Gallo and Davies (23) compared
the colostrum of single- and twin-pregnant ewes and
determined that the colostral IgG levels in the ewes that
had twin births were higher. In the study conducted by
Al-Sabbagh (24), it was reported that the body weight of
a ewe has a direct correlation with the concentration of
IgG in colostrum samples collected 12 h after birth. In
other studies it was reported that there was no correlation
between the sex of the lamb and colostral IgG levels
(25,26).
6. Immunostimulation
The only defence mechanism against the environmental
factors of a neonatal ruminant is the antibodies obtained
from colostrum. The poor nutrition of the dam, immune
system suppression, and stress factors may lead to
inadequate colostral immunoglobulin titres. Besides
the improvement of nutritional and stress conditions,
the stimulation of the immune system by exogenous
methods may increase colostral immunoglobulin titres
(27,28). The regulation of the immune system with some
agents given to an organism exogenously is defined as
“immunostimulation” and the agents used in this process
are called immunostimulants (29).
Immunostimulants are analysed in 2 main groups as
chemical and biological according to their origin. Both
immunostimulant classes may be used for the treatment of
and protection against various infections and may also be
used as adjuvants that cause stronger immune responses
in organisms against the vaccines administered (29,30).
However, the actual expected effect of an immunostimulant
is to decrease the morbidity and mortality rates and increase
weight gain (30). As a result of previous studies, positive
results have been reported in terms of reproductivity by
administration of immunostimulants to ruminants during
advanced pregnancy (30,31).

391

YILMAZ and KAŞIKÇI / Turk J Vet Anim Sci
Major immunostimulants are typically microbial
preparations that can be captured easily by macrophages
such as mycobacteria, anaerobic coryneforms
(Corynebacterium cutis, Propionibacterium acnes, etc.),
and some plant carbohydrates that have a fungal origin
(32,33). Activation of macrophages has been performed
primarily in order for the preparation that was given
to have an immunostimulant effect on the organism.
For the preparation given to the organism to have an
effect, inflammation is the first response of the body
against pathogens. First, the polymorphonuclear cells
(granulocytes) migrate to the region and then invasion
of macrophages takes place. Macrophage activation is
then stimulated either as a result of direct interaction
with antigens or by way of bacterial endotoxins (34).
When these immunostimulants are captured and digested
by macrophages, they stimulate the macrophages to
synthesise cytokines such as interleukin-1 (IL-1), tumour
necrosis factor (TNF), and interleukin-6 (IL-6). After the
release of these cytokines, lymphocytes are activated and
lymphokines such as interleukin-2 (IL-2) and interferon-γ
(IFN-γ) are released. At the end of all of these stages,
resistance to viral infection, natural killer cell (NKC)
activity, production of antibodies, inflammation reactions,
and the level of wound healing increase (30,35–38).
7. Some immunostimulants and their mechanisms
The effect of levamizol used as an anthelmintic on the
immune system arises as the result of a cascade of events
such as phagocytosis, chemotaxis, lymphocyte production,
lymphokinesis production, delay of hypersensibility, and
the formation of interferon and antibodies (39,40).
It has been reported that β-glucan, which is a structural
component of the fungal cell wall, has an immunostimulant
effect by increasing the activity of NKCs, macrophages,
and lymphokine-secreting T-helper cell activity (41,42).
OM-85 (LW-50020, SL-04), which includes
lyophilised bacteria lysate obtained from Haemophilus
influenzae, Streptococcus pneumoniae, Streptococcus
pyogenes, Klebsiella pneumoniae, Klebsiella ozaenae,
Staphylococcus aureus, Staphylococcus viridans, and
Neisseria catarrhalis, has the property of activating the
capacity of polymorphonuclear cells, phagocytic ability
of macrophages, and activation of dendritic cells and
B lymphocytes after it is given to an organism. After
all of these, it exhibits the immunostimulant effect by

stimulating cytokines such as interferon-γ, which has an
important role in fighting infections (41,43).
Today cytokines can be obtained using recombinant
DNA technology and can be used to stimulate the immune
system (44). It has been reported that disruptions in the
production of IL-2 may cause severe immune deficiency
(45,46). Therefore, exogenous application of the cytokine
is expected to activate the immune system (44).
It has been reported that vitamin C (20 mg/kg)
administered to ruminants increases the neutrophil
oxidative mechanisms and antibody-dependent cellular
cytotoxicity mediated by neutrophils (24). Vitamin E,
which can be added to the diet or administered as an
injectable, and selenium support the immune system
by ensuring the stimulation of antibody synthesis,
increasing the migration of leukocytes to the infection
region, strengthening the capacity of phagocytosis, and
preventing the harmful effects of reactive oxygen on the
cell membrane (47).
It has been reported that the agents obtained by
ultrasound from lysates of Corynebacterium cutis
commune are easily phagocytised by macrophages after
the administration of organisms; stimulate the secretion
of TNF, IL-1, and IL-6 by macrophages; and enable the
release of lymphokines, IL-2, and IFN-γ by affecting
secondary lymphocyte function and therefore reactivation
of the immune system. With increasing immunity it is
expected that the rates of morbidity and mortality caused
by bacterial and viral infections will reduce and it is
expected that weight gain will be observed as a result of
improving health care and nutrition. Turna Yılmaz et al.
(48) reported increases in concentrations of colostral IgG
at 0, 36, and 72 h after birth by administration of C. cutis
lysate to pregnant ewes on day 140 of gestation.
8. Conclusion
All organisms just after birth are exposed to some harmful
microorganisms and various stress factors in environmental
conditions. The weakness in the newborn immune system
makes it easy for these factors encountered after birth to
cause some infections in the body. For the fight against
these factors, the antibodies in colostrum provide the
greatest support to newborns. Therefore, it is suggested
that immunostimulation application for pregnant ewes
during pregnancy in order to reduce postnatal morbidity
and mortality rates, increase the live weight gain, and
obtain immunoglobulin-rich colostrum will be helpful.
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